Skip to main content
Premium Trial:

Request an Annual Quote

Telechem Merges with Publicly Traded Communications Firm in $23M Deal

NEW YORK (GenomeWeb News) – Telechem International, the microarray and scanner manufacturer also known as Arrayit, has signed a definitive agreement to merge with publicly traded digital communications firm Integrated Media Holdings in a deal worth roughly $23.1 million.
 
Houston-based Integrated Media Holdings currently trades on the OTC Bulletin Board, and at the close of the market yesterday traded at $.022 per share. However, IMH’s board has approved a 1 for 30 reverse split of the stock, which would up its price to $.66 per share.
 
IMH agreed to acquire Telechem in exchange for 35 million post-split shares, which gives the transaction a value of $23.1 million. As a result of the merger, shareholders of privately held Telechem will own 64.95 percent of the outstanding shares of the merged company.
 
It is unclear whether the combined entity will retain IMH’s name or Telechem’s name.
 
“We believe this will enhance our ability to access capital and further the growth strategy as a leader in the biotech niche we serve,” Rene Schena, CEO of Sunnyvale, Calif.-based Telechem, said in a statement.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.